Institut Paoli-Calmettes: all 172 studies
Page 2 of 2. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.
- Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's OesophagusStatus unknownNCT03278327Not applicable
- Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem CellsStatus unknownNCT03272789Not applicable
- Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic SyndromesStatus unknownNCT03235973Phase 1
- HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid HemopathiesCompletedNCT03232268Phase 1
- Evaluation of the Practice of the TEP Choline at Patients With Prostate CancerStatus unknownNCT03201380
- Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic AgentsActive, not recruitingNCT03185039Not applicable
- Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate CancerCompletedNCT03088124Phase 2
- Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to CastrationCompletedNCT02963155Not applicable
- Evaluation of the Resection of Adenoma and Colic Adenocarcinoma by EMR Piecemeal or EMR/ESD Hybrid TechniqueStatus unknownNCT02935049
- Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell TransplantationStatus unknownNCT02921685Phase 1
- Endoscopic Drainage of Collections After Pancreatic SurgeryCompletedNCT02909296
- Comparison of 2 Techniques of Invasive Mini Surgery: Coelioscopy Mini-trocar and Monotrocar in the Adnexa no Carcinologic Surgery : Forward-looking Observational Study.CompletedNCT02885779
- Biliary Hilar Drainage Managed by EndoscopyStatus unknownNCT02876523
- Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic IndicationsCompletedNCT02865889
- Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation SequencingCompletedNCT02861651
- CONDOL01: Evaluation on the Experience of Bereavement, of a Medical Consultation, Proposed by a Letter of CONDOLence to the Patients' Relatives Versus Standard Practice After the Death of the PatientCompletedNCT02861625
- Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple MyelomaCompletedNCT02861287
- Role of PTK-7 in Acute Myeloid LeukemiasCompletedNCT02860793Not applicable
- Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell TransplantationCompletedNCT02860585
- Evaluation of Oesogastroduodenoscopy With Vision to 245 ° (Full Spectrum Endoscopy) to View the Main Disc and AccessoryCompletedNCT02859883
- Evaluation of the Colonoscope With Vision to 330 ° (Full Spectrum Endoscopy) in the Detection of Colorectal AdenomasCompletedNCT02859870
- Onco-geriatric Database of Patients With Pancreatic CancerStatus unknownNCT02858141
- Adaptated Physical Activity During Chemotherapy: Evaluation of the Psychological, Physiological and Biological ImpactTerminatedNCT02785341Not applicable
- Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)Status unknownNCT02781441Not applicable
- Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and RadiotherapyActive, not recruitingNCT02679040Phase 2
- Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly PatientsCompletedNCT02623309Phase 3
- ChEmo-Genomics Based Treatment of Acute Myeloid LeukemiaStatus unknownNCT02619071Not applicable
- Evaluate Efficacy, Morbidity and Functional Outcome of Endoscopic TranAnal Proctectomy vs Standard Transabdominal Laparoscopic Proctectomy for Rectal CancerCompletedNCT02584985Phase 3
- Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and RectumCompletedNCT02526134Phase 2
- Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With LenalidomideCompletedNCT02525250Not applicable
- Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After TreatmentTerminatedNCT02525211Phase 3
- Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic AdenocarcinomasCompletedNCT02487836Phase 2
- Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate CancerTerminatedNCT02487823Phase 1
- Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood DiseasesCompletedNCT02483325Phase 2
- Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute LeukemiaStatus unknownNCT02345915Not applicable
- Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid TumorsCompletedNCT02342158Not applicable
- Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015CompletedNCT02320656Not applicable
- Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic CancerCompletedNCT02174887Phase 1
- Analysis of the Mechanisms of Actions of Heat Shock Protein (Hsp27) Responsible of the Androgen-independent Evolution in Prostate CancerTerminatedNCT02055846Not applicable
- Evaluation of 3 Different Doses of IV BusulfanCompletedNCT01985061Phase 2
- Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast CancerTerminatedNCT01980277Phase 1/2
- Predictive Clinical and Biological Parameters in Gynecological CancerActive, not recruitingNCT01977274Not applicable
- Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast CancerCompletedNCT01942980Phase 3
- Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's LymphomaCompletedNCT01939327Phase 2
- Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell TransplantationCompletedNCT01853358Phase 1
- Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid HemopathyCompletedNCT01819558Phase 1/2
- Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph NodeActive, not recruitingNCT01717131Not applicable
- Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic TumorsCompletedNCT01692873Not applicable
- Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast CancerTerminatedNCT01589861Phase 1/2
- NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic CancerCompletedNCT01521702Phase 3
- Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation TreatmentStatus unknownNCT01521689Phase 2
- Predictive Clinical and Biological Parameters in Breast CancerTerminatedNCT01521676Not applicable
- Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile DuctCompletedNCT01499537Not applicable
- Triple Negative Breast Cancer: Study of Molecular and Genetic FactorsStatus unknownNCT01434420Not applicable
- Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast CancerCompletedNCT01190345Phase 2
- Personalised Program for Women Treated for Hodgkin DiseaseTerminatedNCT01188915Not applicable
- Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and SurvivalStatus unknownNCT01188330Not applicable
- Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete RemissionCompletedNCT00963521Phase 1
- Natural Killer Cells Function in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00934986Not applicable
- Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct TumorCompletedNCT00930410Not applicable
- Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer PatientsCompletedNCT00930085Not applicable
- Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerCompletedNCT00925418Phase 3
- Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the PancreasCompletedNCT00918853Not applicable
- Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast CancerStatus unknownNCT00912080Not applicable
- Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmCompletedNCT00908869Phase 1
- A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic TransplantationCompletedNCT00894049Phase 2
- Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00840684Phase 1/2
- Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerCompletedNCT00806767Phase 2
- Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to TreatmentCompletedNCT00802568Phase 2
- Stem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersStatus unknownNCT00740467Phase 2
- Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00541021Phase 3
- Natural Killer Cells in Older Patients With Acute Myeloid LeukemiaCompletedNCT00540956Not applicable